OCGN

Conviction 4HealthcareScan · Thu, Sep 24, 2026

Ocugen, Inc. (OCGN) closed at $1.01 (+1.00%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 34, RS Rating 12, -59.3% from its 52-week high, -26.8% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

OCGN$1.01+1.00%

ResistanceSupportVol 14Insider sell

Vol MA14 10.58M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Ocugen, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.ocugen.com ↗

Price1.01

Change+1.00%

Gap-1.01%

Rel volume0.56×

Avg volume8.38M

Avg $ vol9.07M

SMA 201.15

SMA 501.25

SMA 2001.50

Price vs 50-19.38%

Price vs 200-32.75%

MA stackbearish

50/200 cross—

Supertrenddown · 1.21

RSI (14)34

MACD hist-0.01

MACD cross—

Stoch %K / %D10 / 11

ADX (14)27

+DI / −DI13 / 28

RSI divergence—

MACD divergence—

ATR %7.07%

ADR %6.33%

52w high2.48

52w low0.9935

From 52w high-59.27%

Above 52w low+1.66%

New 52w highNo

SqueezeOff

Bollinger width53.44%

%B0.27

Donchian pos8.89%

Donchian high1.42

Donchian low0.9700

AVWAP (52w high)1.50

vs AVWAP high-32.51%

AVWAP (52w low)1.03

vs AVWAP low-1.59%

OBV trendDown

Chaikin MF (20)-0.38

Today vs 20d0.56×

Avg vol (14d)10.58M

Avg vol (20d)8.38M

Avg $ vol (20d)9.07M

Market cap342.5M

RS Rating12 / 99

RS 3m (vs SPY)-30.77%

RS 6m (vs SPY)-65.02%

RS line new highNo

Trend template1/8

Technical rank9.4

1 week-1.94%

1 month-27.86%

3 months-26.28%

6 months-48.21%

1 year-39.16%

YTD-26.81%

P/E-5.05

P/B-20.69

P/S77.61

P/FCF-5.99

EPS-0.2600

Div yield—

ROE409.80%

ROA-54.62%

Debt/Eq-0.11

Current0.80

EV/EBITDA-3.91

Gross margin—

Net margin—

Rev growth8.83%

EPS growth-25.52%

Price target10.13

Target upside902.97%

Analyst ratingBuy

Institutional47.78%

Ent. value244.2M

Revenue1.49M

Net income-24.88M

Gross profit—

Free cash flow-57.15M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out338.52M

Employees116

ListedWed, Dec 3, 2014

Free float298.14M

Float %95.5%

Short interest98.31M

Days to cover28.2d

Short volume69.7%

Squeeze score85 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.07 vs −$0.05

Last surprise-40.0% miss

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank9.4 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.47

Support1.09

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OCGN

All disclosures →

No recent disclosed trades by Congress in OCGN. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OCGN · open-market 2 sells

Insider	Side	Shares	Value	Traded	Filed
Musunuri Shankar Chief Executive Officer · Common Stock · 2026-09-09	Sell	468.73K	$525K	2026-09-09	2026-09-11
Musunuri Shankar Chief Executive Officer · Common Stock · 2026-09-09	Sell	57.26K	$64K	2026-09-09	2026-09-11

SEC filings

EDGAR filings in OCGN · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

OCGN

Recent news

Get daily signals & real-time alerts.